We summarized existing research on weight loss medications in rheumatic disease and their potential for improving quality of ...

Adults with more severe atopic dermatitis are at risk for sleep and memory disturbances, according to results of a recent study.

For adults with chronic low back pain, physical therapy may be beneficial as first-line therapy, according to results of a recent study.

For patients with knee osteoarthritis, combining a cannabinoid medication with an opioid does not provide additional pain relief.

The FDA has approved Saphnelo (anifrolumab-fnia) for subcutaneous administration in patients with systemic lupus ...

A new proposal could make it easier for patients to access breakthrough medical devices through Medicare coverage.

Fracture incidence increases across midlife among women aged 35 through 65 years, while declining among men after age 45.

The risk for HCQ-associated retinopathy increases over time among patients with rheumatic diseases, particularly at higher doses and with prolonged exposure.

The Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License Application (sBLA) for obinutuzumab for the treatment of systemic lupus erythematosus (SLE). Findings ...

About one-third of children and adolescents use dietary supplements in the United States, according to results of a recent study.

Substantial gaps in adult measles, mumps, and rubella vaccination exist, according to results of a recent study.

P004 represents a first-in-class application of GLP-1 receptor agonism in the intra-articular space, specifically targeting patients with knee osteoarthritis and synovitis who have failed multiple ...